Table 3.

Secondary prevention measures across included studies evaluating pharmacist-driven interventions

Study	Timing of Measurement	Results (% Intervention versus % Control)
LDL-C <100 mg/dl
Ho 2014	1 yr	72% vs 83%, p=0.14
Ma 2010	1 yr	65% vs 60%, p=0.29
Hilleman 2001	6 wk	39% vs. 17%, p<0.05
Hilleman 2001	12 wk	51% vs 17%, p<0.05
Hilleman 2001	24 wk	52% vs 18%, p<0.05
Hilleman 2001	1 yr	54% vs 18%, p<0.05
Faulkner 2000	12 wk	67% vs. 67%, p=NR
Faulkner 2000	1 yr	53% vs. 13%, p<0.05
Blood Pressure Goal a
Ho 2014	1 yr	59% vs 49%, p=0.23

^a<140/90mmHg or <130/80 mmHg for patients with diabetes/chronic kidney disease